Condition

Cancer of the Prostate

ClinicalTrials.gov condition label

Clinical trials51
Recruiting7
Common interventions25
Lead sponsors shown15

Clinical trials

51 shown
Low-Count Quantitative SPECT for Men Treated With Radium-223NCT07221825 · 2026-09-01
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28
RECRUITING
Investigation of Impact of AI on Prostate Cancer WorkflowNCT07084779 · 2025-09-09
RECRUITING
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health SystemNCT07109427 · 2025-08-11
RECRUITING
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their CaregiversNCT06363266 · 2025-08-01
RECRUITING
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate CancerNCT05241236 · 2020-11-15
RECRUITING
MRI/Ultrasound Fusion Guided Prostate CryotherapyNCT02381990 · 2013-08-01
RECRUITING
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)NCT07086651 · 2025-07-21
COMPLETED
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerNCT05628363 · 2023-01-18
ACTIVE_NOT_RECRUITING
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCNCT05191017 · 2022-09-01
WITHDRAWN
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNCT05252390 · 2022-03-29
TERMINATED
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNCT04541225 · 2020-12-08
TERMINATED
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).NCT03939689 · 2019-05-30
COMPLETED
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower LimbsNCT03653819 · 2018-09-06
COMPLETED
Proton Boost in Prostate CancerNCT03564275 · 2018-04-16
ACTIVE_NOT_RECRUITING
A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate CancerNCT03392428 · 2018-01-29
COMPLETED
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerNCT03960788 · 2018-01-02
UNKNOWN
Decision Impact Trial of the ExoDx Prostate (IntelliScore)NCT03235687 · 2017-07-19
UNKNOWN
Prostate Cancer Survivors and Exercise and Behavioral CounselingNCT03191968 · 2017-07-06
COMPLETED
Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate CancerNCT03124433 · 2017-06-20
COMPLETED
Cognitive Remediation Therapy (CRT) for Adults Treated for CancerNCT03285048 · 2017-01-01
COMPLETED
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneNCT02640534 · 2016-06-10
TERMINATED
Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot StudyNCT02939456 · 2016-06-01
COMPLETED
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-upNCT04017325 · 2016-03-17
COMPLETED
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer SurvivorsNCT02957357 · 2016-02-01
COMPLETED
Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcerNCT02578940 · 2015-11-01
COMPLETED
Maintaining Suppression of Testosterone With Transdermal Estradiol GelNCT02349386 · 2015-07-01
TERMINATED
The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side EffectsNCT02274350 · 2015-05-01
COMPLETED
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate CancerNCT02349139 · 2015-01-19
TERMINATED
Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ SystemNCT02879851 · 2015-01-01
UNKNOWN
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)NCT02319837 · 2014-12-17
ACTIVE_NOT_RECRUITING
Stereotactic Body Radiotherapy for Stage I-III Prostate CancerNCT02334579 · 2014-12-01
UNKNOWN
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate CancerNCT02079025 · 2013-12-01
COMPLETED
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness TrainingNCT04057859 · 2013-11-01
COMPLETED
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerNCT02003924 · 2013-10-31
COMPLETED
Hemi-Ablative Prostate BrachytherapyNCT02632669 · 2012-07-06
COMPLETED
Sipuleucel-T Manufacturing Demonstration StudyNCT01477749 · 2012-06-01
COMPLETED
Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal DoseNCT02212548 · 2012-03-01
COMPLETED
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)NCT02564120 · 2011-01-01
COMPLETED
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate CancerNCT01303705 · 2010-10-14
COMPLETED
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerNCT00970203 · 2009-09-01
COMPLETED
Eligard Observational Registry for Patients With Prostate CancerNCT00992251 · 2009-08-01
COMPLETED
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerNCT00844792 · 2008-10-01
COMPLETED
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active SurveillanceNCT00744549 · 2008-05-01
COMPLETED
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsNCT02225262 · 2008-01-01
UNKNOWN
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionNCT00643994 · 2007-12-01
COMPLETED
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate CancerNCT00564928 · 2007-11-01
COMPLETED
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryNCT00643617 · 2007-10-22
COMPLETED
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate CancerNCT01897207 · 2002-11-01
COMPLETED
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyNCT02355054
APPROVED_FOR_MARKETING
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyNCT00257478
COMPLETED

Common interventions

EnzalutamideDRUG8PlaceboDRUG5ApalutamideDRUG2CyberKnife Stereotactic RadiosurgeryRADIATION2Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin EDIETARY_SUPPLEMENT2NUV-422DRUG2177Lu-PSMA617OTHER118F-Fluciclovine PET CTDRUG1Active Monitoring dyads' anxietyOTHER1Adaptive stereotactic body radiotherapyRADIATION1AIDEVICE1androgen ablation (AA)BIOLOGICAL1Androgen deprivation therapyDRUG1Annual PSA Health Maintenance ReminderOTHER1Anti-OX40DRUG1ASN001: Escalating dose Part ADRUG1BHR-200 (0.36% transdermal 17β-estradiol gel)DRUG1C-11 Choline PET ImagingDRUG1CabazitaxelDRUG1Cognitive Remediation TherapyBEHAVIORAL1CyberKnife RadiosurgeryRADIATION1CyberKnife Stereotactic Radiosurgery - Intermediate RiskRADIATION1CyberKnife Stereotactic Radiosurgery - Low RiskRADIATION1CyclophosphamideDRUG1DC1 vaccineBIOLOGICAL1

Trial status mix

COMPLETED29
RECRUITING7
TERMINATED5
UNKNOWN5
ACTIVE_NOT_RECRUITING3
APPROVED_FOR_MARKETING1
WITHDRAWN1

Phase mix

NA17
PHASE214
PHASE16
PHASE34
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.